sertraline ODT is one of 54 small molecule programs targeting Panic Disorder. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
744 competitors in Breast Cancer
Adenocard
Duragesic
Rilvegostomig
Tianeptine
Diuretic
Recombinant Human Endostatin
sertraline ODT
4SCAR T Cells
Perflutren Lipid Microsphere
Liposomal Irinotecan and Apatinib
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details